139 related articles for article (PubMed ID: 38537697)
1. Epstein-Barr virus suppresses N
Zhang X; Li Z; Peng Q; Liu C; Wu Y; Wen Y; Zheng R; Xu C; Tian J; Zheng X; Yan Q; Wang J; Ma J
J Biol Chem; 2024 May; 300(5):107226. PubMed ID: 38537697
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
[TBL] [Abstract][Full Text] [Related]
3. Identification of an N6-methyladenosine-mediated positive feedback loop that promotes Epstein-Barr virus infection.
Dai DL; Li X; Wang L; Xie C; Jin Y; Zeng MS; Zuo Z; Xia TL
J Biol Chem; 2021; 296():100547. PubMed ID: 33741341
[TBL] [Abstract][Full Text] [Related]
4. Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus.
Bouvet M; Voigt S; Tagawa T; Albanese M; Chen YA; Chen Y; Fachko DN; Pich D; Göbel C; Skalsky RL; Hammerschmidt W
mBio; 2021 Mar; 12(2):. PubMed ID: 33785626
[TBL] [Abstract][Full Text] [Related]
5. EBV latent membrane protein 1 is a negative regulator of TLR9.
Fathallah I; Parroche P; Gruffat H; Zannetti C; Johansson H; Yue J; Manet E; Tommasino M; Sylla BS; Hasan UA
J Immunol; 2010 Dec; 185(11):6439-47. PubMed ID: 20980631
[TBL] [Abstract][Full Text] [Related]
6. N(6)-methyladenosine-binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay.
Xia TL; Li X; Wang X; Zhu YJ; Zhang H; Cheng W; Chen ML; Ye Y; Li Y; Zhang A; Dai DL; Zhu QY; Yuan L; Zheng J; Huang H; Chen SQ; Xiao ZW; Wang HB; Roy G; Zhong Q; Lin D; Zeng YX; Wang J; Zhao B; Gewurz BE; Chen J; Zuo Z; Zeng MS
EMBO Rep; 2021 Apr; 22(4):e50128. PubMed ID: 33605073
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.
Martin HJ; Lee JM; Walls D; Hayward SD
J Virol; 2007 Sep; 81(18):9748-58. PubMed ID: 17609264
[TBL] [Abstract][Full Text] [Related]
8. EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection.
van Gent M; Griffin BD; Berkhoff EG; van Leeuwen D; Boer IG; Buisson M; Hartgers FC; Burmeister WP; Wiertz EJ; Ressing ME
J Immunol; 2011 Feb; 186(3):1694-702. PubMed ID: 21191071
[TBL] [Abstract][Full Text] [Related]
9. RNA m
Zheng X; Wang J; Zhang X; Fu Y; Peng Q; Lu J; Wei L; Li Z; Liu C; Wu Y; Yan Q; Ma J
Immun Inflamm Dis; 2021 Jun; 9(2):351-362. PubMed ID: 33434416
[TBL] [Abstract][Full Text] [Related]
10. SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway.
Ou C; Sun Z; Zhang H; Xiong W; Ma J; Zhou M; Lu J; Zeng Z; Bo X; Chen P; Li G; Li X; Li X
Oncol Rep; 2015 Jun; 33(6):2779-88. PubMed ID: 25891128
[TBL] [Abstract][Full Text] [Related]
11. The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease.
Hatton OL; Harris-Arnold A; Schaffert S; Krams SM; Martinez OM
Immunol Res; 2014 May; 58(2-3):268-76. PubMed ID: 24619311
[TBL] [Abstract][Full Text] [Related]
12. [Regulation and evasion of host immune responses by Epstein-Barr virus].
Xiao N; Chen Q; Cai S
Wei Sheng Wu Xue Bao; 2016 Jan; 56(1):19-25. PubMed ID: 27305776
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
[TBL] [Abstract][Full Text] [Related]
14. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B
mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.
Albanese M; Tagawa T; Bouvet M; Maliqi L; Lutter D; Hoser J; Hastreiter M; Hayes M; Sugden B; Martin L; Moosmann A; Hammerschmidt W
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6467-E6475. PubMed ID: 27698133
[TBL] [Abstract][Full Text] [Related]
16. Caspases Switch off the m
Zhang K; Zhang Y; Maharjan Y; Sugiokto FG; Wan J; Li R
mBio; 2021 Aug; 12(4):e0170621. PubMed ID: 34425696
[TBL] [Abstract][Full Text] [Related]
17. Immune Evasion by Epstein-Barr Virus.
Ressing ME; van Gent M; Gram AM; Hooykaas MJ; Piersma SJ; Wiertz EJ
Curr Top Microbiol Immunol; 2015; 391():355-81. PubMed ID: 26428381
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr Virus Envelope Glycoprotein gp110 Inhibits IKKi-Mediated Activation of NF-κB and Promotes the Degradation of β-Catenin.
Guo Y; Pan L; Wang L; Wang S; Fu J; Luo W; Wang K; Li X; Huang C; Liu Y; Kang H; Zeng Q; Fu X; Huang Z; Li W; He Y; Li L; Peng T; Yang H; Li M; Xiao B; Cai M
Microbiol Spectr; 2023 Jun; 11(3):e0032623. PubMed ID: 37022262
[TBL] [Abstract][Full Text] [Related]
19. RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes.
Wang C; Li D; Zhang L; Jiang S; Liang J; Narita Y; Hou I; Zhong Q; Zheng Z; Xiao H; Gewurz BE; Teng M; Zhao B
J Virol; 2019 Jul; 93(13):. PubMed ID: 31019051
[TBL] [Abstract][Full Text] [Related]
20. Lactoferrin suppresses the Epstein-Barr virus-induced inflammatory response by interfering with pattern recognition of TLR2 and TLR9.
Zheng Y; Qin Z; Ye Q; Chen P; Wang Z; Yan Q; Luo Z; Liu X; Zhou Y; Xiong W; Ma J; Li G
Lab Invest; 2014 Nov; 94(11):1188-99. PubMed ID: 25068657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
